MEMO-Medical Marijuana and Opioids Study
NCT03268551 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 257
Last updated 2023-11-08
Summary
The study will examine how medical cannabis use affects opioid analgesic use over time, with particular attention to THC/CBD content, HIV outcomes, and severe adverse events.
Conditions
- Opioid Use
- Marijuana
- Chronic Pain
- HIV/AIDS
Sponsors & Collaborators
-
Fordham University
collaborator OTHER - collaborator OTHER
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Albert Einstein College of Medicine
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-04
- Primary Completion
- 2023-07-14
- Completion
- 2023-07-14
Countries
- United States
Study Locations
More Related Trials
-
Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults
NCT01052662 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cannabis and Opioid Use Disorder
NCT05729932 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Tolerability of Cannabidiol Among Persons With Opioid Use Disorder Receiving Methadone or Buprenorphine
NCT05076370 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Memantine and Naltrexone Treatment for Opioid Dependence
NCT00125515 ·Status: COMPLETED ·Phase: PHASE2
-
Methadone Maintenance & HIV Risk in Ukraine
NCT00351026 ·Status: COMPLETED ·Phase: PHASE3
-
Autobiographical Memory in Opioid Use Disorder
NCT06643988 ·Status: RECRUITING ·Phase: NA
-
Impact on Opioid Use of Bundling Medication-assisted Treatment With mHealth
NCT02712034 ·Status: COMPLETED ·Phase: NA
-
Adversity, Brain and Opioid Use Study
NCT06355778 ·Status: RECRUITING ·Phase: NA
-
Medication Adherence Therapy for Opioid Abusing Pain Patients
NCT00249587 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cognitive Function and Pain Threshold in People Who Are Methadone Maintained
NCT04027166 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Psilocybin for Opioid Use Disorder (OUD)
NCT06796062 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
NCT00000210 ·Status: COMPLETED ·Phase: PHASE2
-
Pain, Inflammation and Opioid Craving
NCT04190563 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine Group Medical Visits in Primary Care
NCT02526212 ·Status: COMPLETED ·Phase: PHASE3
-
Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior
NCT03221309 ·Status: COMPLETED
-
Prevention Interventions for Opioid Misuse
NCT04550715 ·Status: COMPLETED ·Phase: NA
-
Mindfulness Oriented Recovery Enhancement for Chronic Pain and Opioid Relapse
NCT04491968 ·Status: COMPLETED ·Phase: NA
-
Effects of RME on Engagement in Buprenorphine Treatment
NCT05184907 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1
NCT00142935 ·Status: COMPLETED ·Phase: NA
-
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
NCT04480554 ·Status: TERMINATED ·Phase: PHASE2
-
Mindfulness Oriented Recovery Enhancement in Hospitalized People With Opioid Use Disorder
NCT05066321 ·Status: TERMINATED ·Phase: NA
-
Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP
NCT05108935 ·Status: COMPLETED ·Phase: NA
-
Screen, Treat and Retain People With Primary Meth Use Disorder at MMT Clinics
NCT07121296 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Leveraging Social Networks to Increase COVID-19 Testing Uptake
NCT04873401 ·Status: COMPLETED ·Phase: NA
-
TMC278-TiDP6-C121: Drug-drug Interaction Trial to Investigate the Potential Interaction Between TMC278 25 mg Daily and Methadone, at Steady State.
NCT00744770 ·Status: COMPLETED ·Phase: PHASE1